https://t.co/p5wwSOBPHt The first severe COVID-19 patient successfully treated with human recombinant soluble ACE2 (hrsACE2), with disappearance of coronavirus swiftly from the serum, nasal cavity and lungs, and a reduction of inflammatory cytokine levels,
Human recombinant soluble ACE2 (hrsACE2) shows promise for treating severe COVID19 | Signal Transduction and Targeted Therapy https://t.co/o8IkzsFdA1
Human recombinant soluble ACE2 (hrsACE2) shows promise for treating severe COVID19 https://t.co/kVuvfEHR9R
@__ice9 finally! Been waiting for this since March. https://t.co/5ClmmIuisv
First case reported in humans of a soluble ACE2 protein (the receptor SARS-CoV-2 uses to infect cells) resolving severe Covid19 infection. https://t.co/qeO2hCS3CI
Brilliant!! Human recombinant soluble ACE2 (hrsACE2) shows promise for treating severe COVID19 | Signal Transduction and Targeted Therapy https://t.co/fW96sXgOkb
The first severe COVID-19 patient successfully treated with human recombinant soluble ACE2 (hrsACE2), with disappearance of coronavirus swiftly from the serum, nasal cavity and lungs, and a reduction of inflammatory cytokine levels https://t.co/1zsxeWKcOz
“The published data document upon treatment of an adaptive immune response, the disappearance of the virus swiftly from the serum, the nasal cavity and lungs, and a reduction of inflammatory cytokine levels that are critical for COVID-19 pathology.” https:
The first severe COVID-19 patient successfully treated with human recombinant soluble ACE2 (hrsACE2), with disappea https://t.co/Bt5vBrypfU https://t.co/I0EzU7mWH7
Human recombinant soluble ACE2 (hrsACE2) shows promise for treating severe COVID19 | Signal Transduction and Targeted Therapy https://t.co/zmYTWJ0CpZ
#Medicine The first severe COVID-19 patient successfully treated with human recombinant soluble ACE2 (hrsACE2), with disappearance of coronavirus swiftly from the serum, nasal cavity and lungs, and a reduction of inflammatory cytokine levels, leading to...
#JosefPenninger #APN01 November 3, 2020: "Human recombinant soluble ACE2 (hrsACE2) shows promise for treating severe COVID19" by Tarek Mohamed Abd El-Aziz, Ahmed Al-Sabi, et al: https://t.co/aYU73GPoMm